Literature DB >> 21326801

Carotid intervention 3: the evidence for cerebral protection.

Fabrizio Fanelli1, Mario Bezzi, Emanuele Boatta, Roberto Passariello.   

Abstract

Carotid stenting is a safe alternative option to conventional carotid endarterectomy in the treatment of carotid artery stenosis in patients considered poor candidates for surgery or who choose not to have open surgery. During the stenting procedure, however, distal embolization may occur with neurological sequelae. To reduce the incidence of this, several cerebral-protection devices (CPDs) have been developed. Different types of CPDs are now commercially available: distal occlusion balloons, distal filters, and proximal protection devices with or without reversal of flow. But complications can occur with their use and are usually associated with an inability to cross the lesion, failure to capture the emboli, vasospasm, and vessel wall injury. Because protection devices are currently the focus of interest by manufacturers and physicians, several trials are going on worldwide to analyze the characteristics of each of them and to evaluate their efficacy in reducing the rate of distal embolization.

Entities:  

Keywords:  Cerebral embolization; balloon occlusion; filters; flow reversal

Year:  2007        PMID: 21326801      PMCID: PMC3036422          DOI: 10.1055/s-2007-980046

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  32 in total

Review 1.  Carotid artery stenting: utility of cerebral protection devices.

Authors:  T Ohki; F J Veith
Journal:  J Invasive Cardiol       Date:  2001-01       Impact factor: 2.022

2.  Initial evaluation of carotid angioplasty and stenting with three different cerebral protection devices.

Authors:  J C Parodi; R La Mura; L M Ferreira; M V Mendez; H Cersósimo; C Schönholz; G Garelli
Journal:  J Vasc Surg       Date:  2000-12       Impact factor: 4.268

3.  Embolic risk of the different stages of carotid bifurcation balloon angioplasty: an experimental study.

Authors:  M Coggia; O Goëau-Brissonnière; J L Duval; J P Leschi; M Letort; M D Nagel
Journal:  J Vasc Surg       Date:  2000-03       Impact factor: 4.268

4.  Algorithm for difficult distal protection system retrieval in carotid stenting.

Authors:  Lowell F Satler
Journal:  Catheter Cardiovasc Interv       Date:  2006-02       Impact factor: 2.692

Review 5.  Early outcome of carotid angioplasty and stenting with and without cerebral protection devices: a systematic review of the literature.

Authors:  Andreas Kastrup; Klaus Gröschel; Hilmar Krapf; Bernhard R Brehm; Johannes Dichgans; Jörg B Schulz
Journal:  Stroke       Date:  2003-02-13       Impact factor: 7.914

6.  Brain microemboli associated with cardiopulmonary bypass: a histologic and magnetic resonance imaging study.

Authors:  D M Moody; W R Brown; V R Challa; D A Stump; D M Reboussin; C Legault
Journal:  Ann Thorac Surg       Date:  1995-05       Impact factor: 4.330

7.  Carotid artery stenting protected with an emboli containment system.

Authors:  Patrick L Whitlow; Pedro Lylyk; Hugo Londero; Oscar A Mendiz; Klaus Mathias; Horst Jaeger; Juan Parodi; Claudio Schönholz; Jose Milei
Journal:  Stroke       Date:  2002-05       Impact factor: 7.914

8.  Effect of the distal-balloon protection system on microembolization during carotid stenting.

Authors:  N Al-Mubarak; G S Roubin; J J Vitek; S S Iyer; G New; M B Leon
Journal:  Circulation       Date:  2001-10-23       Impact factor: 29.690

9.  Impact of cerebral protection devices on early outcome of carotid stenting.

Authors:  Fausto Castriota; Alberto Cremonesi; Raffaella Manetti; Armando Liso; Kareem Oshola; Enrico Ricci; Guido Balestra
Journal:  J Endovasc Ther       Date:  2002-12       Impact factor: 3.487

10.  Belgian experience with FilterWire EX in the prevention of embolic events during carotid stenting.

Authors:  Marc Bosiers; Patrick Peeters; Jurgen Verbist; Herman Schroë; Koen Deloose; Geert Lauwers; Luc Stockx
Journal:  J Endovasc Ther       Date:  2003-08       Impact factor: 3.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.